- Home
- CRDF vs FDBC Comparison
CRDF vs FDBC Comparison
Compare CRDF & FDBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- FDBC
- Stock Information
- Founded
- CRDF 1999
- FDBC 1902
- Country
- CRDF United States
- FDBC United States
- Employees
- CRDF N/A
- FDBC N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- FDBC Major Banks
- Sector
- CRDF Health Care
- FDBC Finance
- Exchange
- CRDF Nasdaq
- FDBC Nasdaq
- Market Cap
- CRDF 196.2M
- FDBC 226.2M
- IPO Year
- CRDF N/A
- FDBC N/A
- Fundamental
- Price
- CRDF $2.66
- FDBC $40.34
- Analyst Decision
- CRDF Strong Buy
- FDBC
- Analyst Count
- CRDF 4
- FDBC 0
- Target Price
- CRDF $12.25
- FDBC N/A
- AVG Volume (30 Days)
- CRDF 1.1M
- FDBC 6.5K
- Earning Date
- CRDF 05-08-2025
- FDBC 04-23-2025
- Dividend Yield
- CRDF N/A
- FDBC 3.94%
- EPS Growth
- CRDF N/A
- FDBC 32.67
- EPS
- CRDF N/A
- FDBC 3.76
- Revenue
- CRDF $587,000.00
- FDBC $81,621,000.00
- Revenue This Year
- CRDF N/A
- FDBC N/A
- Revenue Next Year
- CRDF N/A
- FDBC N/A
- P/E Ratio
- CRDF N/A
- FDBC $11.02
- Revenue Growth
- CRDF N/A
- FDBC 15.50
- 52 Week Low
- CRDF $2.01
- FDBC $37.00
- 52 Week High
- CRDF $5.64
- FDBC $61.21
- Technical
- Relative Strength Index (RSI)
- CRDF 42.40
- FDBC 48.15
- Support Level
- CRDF $2.42
- FDBC $40.54
- Resistance Level
- CRDF $2.87
- FDBC $41.50
- Average True Range (ATR)
- CRDF 0.19
- FDBC 1.20
- MACD
- CRDF 0.01
- FDBC 0.29
- Stochastic Oscillator
- CRDF 27.91
- FDBC 50.09
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About FDBC Fidelity D & D Bancorp Inc.
Fidelity D & D Bancorp Inc is a bank holding company. Through its wholly-owned state-chartered commercial bank subsidiary, The Fidelity Deposit and Discount Bank (the Bank), it offers a full range of traditional banking services. The Bank has a personal and corporate trust department and also provides alternative financial and insurance products with asset management services. Its primary market areas are Lackawanna, Luzerne and Northampton Counties, Pennsylvania. The company's primary deposit products are demand deposits and interest-bearing time, money market and savings accounts. It offers a full array of loan products to meet the needs of retail and commercial customers. Company includes segments: Commercial and Industrial, Commercial Real Estate, Consumer, Residential Real Estate.